PRODUCTION OF RECOMBINANT HTLV-II ENVELOPE PROTEIN IN E. COLI

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$45,000.00
Award Year:
1990
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
13744
Agency Tracking Number:
13744
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
950 Boston Ave, Longmont, CO, 80501
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Yitzhak Stabinsky
(303) 651-6419
Business Contact:
() -
Research Institution:
n/a
Abstract
HUMAN T-CELL LEUKEMIA VIRUS TYPE II (HTLV-II) IS CONSIDERED TO BE AN ETIOLOGIC AGENT OF HAIRY CELL LEUKEMIA, AND ITS PREVALENCE IS INCREASING IN THE BLOOD SUPPLY. THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO PRODUCE AN IMMUNOLOGICAL ASSAY TO STUDY ITS PREVALENCE IN THE BLOOD SUPPLY. THIS PHASE I RESEARCH SPECIFICALLY AIMS TO DEVELOP A RECOMBINANT DNA SYSTEM TO PRODUCE A PORTION OF THE ENVELOPE PROTEIN THAT IS IMMUNOGENIC. THE APPROACH TO BE USED WILL INVOLVE THE ASSEMBLY OF A SYNTHETIC GENE CODING FOR THAT PORTION OF THE ENVELOPE PROTEIN. THE GENE WILL BE CLONED AND EXPRESSED IN E. COLI. HIGH-LEVEL EXPRESSION OF THE DESIRED PRODUCT WILL ENABLE PHASE II RESEARCH TO FOCUS ON THE E. COLI FERMENTATION SCALE-UP AND PURIFICATION.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government